The Advisory Board Company Schedules Earnings Conference Call for the Quarter Ended September 30, 2013

Tue Oct 22, 2013 9:38am EDT

* Reuters is not responsible for the content in this press release.

The Advisory Board Company Schedules Earnings Conference Call for the Quarter Ended September 30, 2013

PR Newswire

WASHINGTON, Oct. 22, 2013 /PRNewswire/ -- The Advisory Board Company (NASDAQ: ABCO) announced today that it will hold a conference call hosted by Robert W. Musslewhite, Chief Executive Officer and Michael T. Kirshbaum, Chief Financial Officer, to discuss the Company's financial results for the quarter ended September 30, 2013.  The call will be held on Monday, November 4, 2013, at 5:30 p.m., Eastern Time.  The Company plans to release its financial results for the quarter ended September 30, 2013 after the market closes on Monday, November 4, 2013.

(Logo: http://photos.prnewswire.com/prnh/20110802/PH45999LOGO )

The conference call will be available via live webcast in the Investor Relations section of the Company's website at www.advisory.com/IR.  To participate by telephone, the dial-in number is 888.317.6016.  Call participants are advised to dial in at least five minutes prior to the call to register.  The webcast will be archived for seven days: from 8:00 p.m., Eastern Time, Monday, November 4, 2013, until 11:00 p.m., Eastern Time, Monday, November 11, 2013.

About The Advisory Board Company

The Advisory Board Company is a global research, technology, and consulting firm partnering with 4,100 organizations and more than 165,000 leaders across health care and higher education.  Through its innovative membership model, the Company collaborates with executives and their teams to elevate performance and solve their most pressing challenges.  The Company provides strategic guidance, actionable insights, web-based software solutions, and comprehensive implementation and management services.  For more information, visit the firm's website, www.advisory.com.

 

SOURCE The Advisory Board Company

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.